Institution · Solvo Biotechnology (Hungary)
Most cited papers from Solvo Biotechnology (Hungary)
What are the most cited papers from Solvo Biotechnology (Hungary)?
The most cited paper from Solvo Biotechnology (Hungary) is "The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity" (Hristos Glavinas, Péter Krajcsi, Judit Cserepes et al., 2004), with 564 citations. Next come "Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect Cells" (318) and "ABCC2/Abcc2: a multispecific transporter with dominant excretory functions" (140).
Showing 50 of 60 papers. Every paper with more than 22 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity Hristos Glavinas, Péter Krajcsi, Judit Cserepes et al. · Current Drug Delivery | 2004 | 564 |
| 2 | Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect Cells Csilla Özvegy, Thomas Litman, Gergely Szakács et al. · Biochemical and Biophysical Research Communications | Jul 2001 | 318 |
| 3 | ABCC2/Abcc2: a multispecific transporter with dominant excretory functions Katalin Jemnitz, Krisztina Herédi‐Szabó, Judit Jánossy et al. · Drug Metabolism Reviews | 19 Jan 2010 | 140 |
| 4 | Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3) Anne Lespine, Jacques Dupuy, Stéphane Orlowski et al. · Chemico-Biological Interactions | 28 Dec 2005 | 124 |
| 5 | Mechanistic study on the intestinal absorption and disposition of baicalein Zhang Li, Ge Lin, Bernadett Kalapos‐Kovács et al. · European Journal of Pharmaceutical Sciences | 25 Apr 2007 | 117 |
| 6 | Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2 Ákos Pál, Dóra Méhn, E. M. Molnar et al. · Journal of Pharmacology and Experimental Therapeutics | 9 Mar 2007 | 110 |
| 7 | Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization Judit Cserepes, Zsófia Szentpétery, Laszlo Seres et al. · Biochemical and Biophysical Research Communications | Jul 2004 | 105 |
| 8 | Utilization of membrane vesicle preparations to study drug–ABC transporter interactions Hristos Glavinas, Dóra Méhn, Márton Jani et al. · Expert Opinion on Drug Metabolism & Toxicology | Jun 2008 | 99 |
| 9 | Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors Emese Kis, Enikő Ioja, Tünde Nagy et al. · Drug Metabolism and Disposition | 12 Jun 2009 | 94 |
| 10 | Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1 Andrea Dreiseitel, Berend Oosterhuis, KV Vukman et al. · British Journal of Pharmacology | 17 Nov 2009 | 88 |
| 11 | Interaction of Positional Isomers of Quercetin Glucuronides with the Transporter ABCC2 (cMOAT, MRP2) Gary Williamson, Isabelle Herter‐Aeberli, Laurence Miguet et al. · Drug Metabolism and Disposition | 4 May 2007 | 82 |
| 12 | Age-Related Functional and Expressional Changes in Efflux Pathways at the Blood-Brain Barrier Franciska Erdő, Péter Krajcsi · Frontiers in Aging Neuroscience | 30 Jul 2019 | 78 |
| 13 | Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation Md Masud Parvez, Abdul Basit, Parth B. Jariwala et al. · Drug Metabolism and Disposition | Jun 2021 | 77 |
| 14 | Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics Márton Jani, Csilla Temesszentandrási‐Ambrus, Rémi Magnan et al. · Archives of Toxicology | 28 Apr 2014 | 75 |
| 15 | Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance Esztella-Éva Kis, Tünde Nagy, Marghi Jani et al. · Annals of the Rheumatic Diseases | 9 Apr 2008 | 74 |
| 16 | P-glycoprotein inhibition by membrane cholesterol modulation Ferenc Fenyvesi, Éva Fenyvesi, Lajos Szente et al. · European Journal of Pharmaceutical Sciences | 30 Apr 2008 | 74 |
| 17 | Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney Cindy Yanfei Li, Abdul Basit, Anshul Gupta et al. · The Journal of Steroid Biochemistry and Molecular Biology | 5 Apr 2019 | 73 |
| 18 | ABCG2 (Breast Cancer Resistance Protein/Mitoxantrone Resistance-Associated Protein) ATPase Assay: A Useful Tool to Detect Drug-Transporter Interactions Hristos Glavinas, Emese Kis, Ákos Pál et al. · Drug Metabolism and Disposition | 31 May 2007 | 71 |
| 19 | Third-generation Sequencing Reveals Extensive Polycistronism and Transcriptional Overlapping in a Baculovirus Norbert Moldován, Dóra Tombácz, Attila László Szűcs et al. · Scientific Reports | 30 May 2018 | 69 |
| 20 | A novel screening strategy to identify ABCB1 substrates and inhibitors Oliver von Richter, Hristos Glavinas, Péter Krajcsi et al. · Naunyn-Schmiedeberg s Archives of Pharmacology | 28 Aug 2008 | 69 |
| 21 | Multiple ABC Transporters Efflux Baicalin Bernadett Kalapos‐Kovács, Balázs Magda, Márton Jani et al. · Phytotherapy Research | 24 Sep 2015 | 64 |
| 22 | Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays Csilla Hegedüs, Gergely Szakács, László Homolya et al. · Advanced Drug Delivery Reviews | 25 Dec 2008 | 63 |
| 23 | ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors Zsolt Sáfár, Emese Kis, Franciska Erdő et al. · Expert Opinion on Drug Metabolism & Toxicology | 11 Mar 2019 | 62 |
| 24 | Transcriptional response of P. pastoris in fed-batch cultivations to Rhizopus oryzae lipase production reveals UPR induction David Resina, Mónika Bollók, Narendar K. Khatri et al. · Microbial Cell Factories | 16 Jul 2007 | 60 |
| 25 | Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp) Ulrich Schmitt, A. Abou El-Ela, Lianrui Guo et al. · Journal of Neural Transmission | 26 Oct 2005 | 58 |
| 26 | BSEP inhibition – In vitro screens to assess cholestatic potential of drugs Emese Kis, Enikő Ioja, Zsuzsa Rajnai et al. · Toxicology in Vitro | 19 Nov 2011 | 58 |
| 27 | Hepatic Metabolism and Disposition of Baicalein via the Coupling of Conjugation Enzymes and Transporters—In Vitro and In Vivo Evidences Zhang Li, Chenrui Li, Ge Lin et al. · The AAPS Journal | 24 May 2011 | 58 |
| 28 | A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters Péter Tátrai, Patrick Schweigler, Birk Poller et al. · Drug Metabolism and Disposition | 9 May 2019 | 57 |
| 29 | Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters Ágnes Telbisz, Csilla Temesszentandrási‐Ambrus, Orsolya Mózner et al. · Pharmaceutics | 9 Jan 2021 | 49 |
| 30 | Ivermectin Interacts With Human ABCG2 Márton Jani, Ildikó Makai, Emese Kis et al. · Journal of Pharmaceutical Sciences | 22 Jun 2010 | 45 |
| 31 | Interactions of bilastine, a new oral H1antihistamine, with human transporter systems María Luisa Lucero, Ana Gonzalo, Álvaro Ganza et al. · Drug and Chemical Toxicology | 22 May 2012 | 44 |
| 32 | Quantitative Systems Toxicology Analysis ofIn VitroMechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury Diane Longo, Jeffrey L. Woodhead, PAUL A. WALKER et al. · Toxicological Sciences | 4 Oct 2018 | 43 |
| 33 | Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions Harma M. Ellens et al. · Drug Metabolism and Disposition | 26 Apr 2013 | 43 |
| 34 | Characterization of 5(6)-Carboxy-2,′7′-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4 Krisztina Herédi‐Szabó, Emese Kis, E. M. Molnar et al. · SLAS DISCOVERY | 18 Mar 2008 | 43 |
| 35 | Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics Kazuya Ishida, Mohammed Ullah, Beáta Tóth et al. · Drug Metabolism and Disposition | 30 Oct 2017 | 41 |
| 36 | Specific interactions of chloroacetanilide herbicides with human ABC transporter proteins Berend Oosterhuis, Vukman Krisztina, Vági Erika et al. · Toxicology | 15 Mar 2008 | 40 |
| 37 | Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics Csilla Temesszentandrási‐Ambrus, Éva Bakos, Balázs Sarkadi et al. · Scientific Reports | 8 Sep 2021 | 39 |
| 38 | Protective Role of Decorin in Primary Hepatocellular Carcinoma Andrea Reszegi, Zsolt Horváth, Hajnalka Fehér et al. · Frontiers in Oncology | 12 May 2020 | 39 |
| 39 | Decorin in the Tumor Microenvironment Kornélia Baghy, Andrea Reszegi, Péter Tátrai et al. · Advances in experimental medicine and biology | 2020 | 38 |
| 40 | Calcein assay: a high-throughput method to assess P-gp inhibition Hristos Glavinas, Oliver von Richter, Kinga Vojnits et al. · Xenobiotica | 9 Jun 2011 | 38 |
| 41 | Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus‐infected Sf9 cells Walter Brand, Berend Oosterhuis, Péter Krajcsi et al. · Biopharmaceutics & Drug Disposition | 15 Nov 2011 | 38 |
| 42 | Kinetic Characterization of Sulfasalazine Transport by Human ATP-Binding Cassette G2 Márton Jani, Pál Tamás Szabó, Emese Kis et al. · Biological and Pharmaceutical Bulletin | 2009 | 37 |
| 43 | Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP‐binding cassette transporters Chi Chun Wong, Denís Barron, Caroline Orfila et al. · Molecular Nutrition & Food Research | 29 Apr 2011 | 37 |
| 44 | A P-gp vesicular transport inhibition assay – Optimization and validation for drug–drug interaction testing Krisztina Herédi‐Szabó, Johan E. Palm, Tommy B. Andersson et al. · European Journal of Pharmaceutical Sciences | 15 May 2013 | 36 |
| 45 | Syndecan-1 in liver pathophysiology Andrea Reszegi, Péter Tátrai, Eszter Regős et al. · American Journal of Physiology-Cell Physiology | 15 Jun 2022 | 35 |
| 46 | Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach Vineet Kumar, Mengyue Yin, Kazuya Ishida et al. · Drug Metabolism and Disposition | 14 Oct 2020 | 35 |
| 47 | Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties Marianna Fantin, Luigi Quintieri, Erzsébet Kúsz et al. · European Journal of Pharmacology | Mar 2006 | 35 |
| 48 | The expressions of ABCC4 and ABCG2 xenobiotic transporters in human keratinocytes are proliferation-related Attila Bebes, Kornélia Kis, Tünde Nagy et al. · Archives of Dermatological Research | 16 Sep 2011 | 33 |
| 49 | Multidrug Resistance Protein 2-Mediated Estradiol-17β-d-glucuronide Transport Potentiation: In Vitro-in Vivo Correlation and Species Specificity Krisztina Herédi‐Szabó, Hristos Glavinas, Esztella-Éva Kis et al. · Drug Metabolism and Disposition | 2009 | 32 |
| 50 | Quinidine as an ABCB1 Probe for Testing Drug Interactions at the Blood–Brain Barrier: An In Vitro In Vivo Correlation Study Istvan Sziráki, Franciska Erdő, Erzsébet Beéry et al. · SLAS DISCOVERY | 11 Aug 2011 | 31 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.